Nothing Special   »   [go: up one dir, main page]

AU2001286586A1 - Trance regulation of chondrocyte differentiation - Google Patents

Trance regulation of chondrocyte differentiation

Info

Publication number
AU2001286586A1
AU2001286586A1 AU2001286586A AU8658601A AU2001286586A1 AU 2001286586 A1 AU2001286586 A1 AU 2001286586A1 AU 2001286586 A AU2001286586 A AU 2001286586A AU 8658601 A AU8658601 A AU 8658601A AU 2001286586 A1 AU2001286586 A1 AU 2001286586A1
Authority
AU
Australia
Prior art keywords
trance
regulation
chondrocyte differentiation
chondrocyte
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286586A
Inventor
Yongwon Choi
Sandy C. Marks Jr.
Paul R. Odgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts Medical Center
Original Assignee
University of Massachusetts Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts Medical Center filed Critical University of Massachusetts Medical Center
Publication of AU2001286586A1 publication Critical patent/AU2001286586A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001286586A 2000-08-18 2001-08-20 Trance regulation of chondrocyte differentiation Abandoned AU2001286586A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22619700P 2000-08-18 2000-08-18
US60/226,197 2000-08-18
PCT/US2001/026101 WO2002016551A2 (en) 2000-08-18 2001-08-20 Trance regulation of chondrocyte differentiation

Publications (1)

Publication Number Publication Date
AU2001286586A1 true AU2001286586A1 (en) 2002-03-04

Family

ID=22847964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286586A Abandoned AU2001286586A1 (en) 2000-08-18 2001-08-20 Trance regulation of chondrocyte differentiation

Country Status (3)

Country Link
US (1) US20040247596A1 (en)
AU (1) AU2001286586A1 (en)
WO (1) WO2002016551A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2284203T5 (en) 1997-04-16 2016-03-11 Amgen Inc. Osteoprotegerin binding proteins and their receptors
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
AU2001293030B2 (en) 2000-09-22 2007-07-19 Immunex Corporation Screening assays for agonists or antagonists of receptor activat or of NF-kB
DE60235989D1 (en) 2001-06-26 2010-05-27 Amgen Fremont Inc ANTIBODIES AGAINST OPGL
US7700574B2 (en) 2003-09-17 2010-04-20 Isis Pharmaceuticals, Inc. Modulation of RANKL expression
WO2006010376A1 (en) * 2004-07-28 2006-02-02 Aic Method for diagnosing and treating bone-related diseases
BR112014013757A2 (en) 2011-12-09 2019-08-27 Metabolic Pharmaceuticals Pty Ltd method for treating osteoarthritis; method for treating a condition involving insufficient functional chondrocytes or insufficient functional cartilaginous tissue; and use of a peptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US5723331A (en) * 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US5710013A (en) * 1996-04-19 1998-01-20 Tularik Inc. Tumor necrosis factor receptor associated factor 6 (TRAF6)
WO1998028426A2 (en) * 1996-12-23 1998-07-02 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
ES2284203T5 (en) * 1997-04-16 2016-03-11 Amgen Inc. Osteoprotegerin binding proteins and their receptors
WO1999029865A2 (en) * 1997-12-12 1999-06-17 The Rockefeller University A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof

Also Published As

Publication number Publication date
WO2002016551A2 (en) 2002-02-28
WO2002016551A3 (en) 2003-03-13
US20040247596A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
AU2002359923A1 (en) 6-fluorobicyclo[3.1.0]hexane derivatives
AU2001278161A1 (en) Nutritional supplement for the management of weight
AU2001282449A1 (en) Applications of the biofeedback technique
AU6274298A (en) Growth differentiation factor-8
AU6364700A (en) Human synthetases
AU8037800A (en) Staggered independent suspension
AU2058701A (en) Esters of vitamin D3 and uses thereof
AU7497798A (en) 3-epi compounds of vitamin d3 and uses thereof
AUPR209000A0 (en) Regulation of bacterial virulence
AU2001286586A1 (en) Trance regulation of chondrocyte differentiation
AU2413299A (en) Novel vitamin d3 amide derivatives
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU4415501A (en) Regulation of human gelatinase b-like enzyme 1
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2001295602A1 (en) Regulation of human phospholipase a2-like enzyme
AU1153201A (en) Uses of 1,25-dihydroxy-5,6-trans vitamin D compounds and derivatives thereof
AU2002212318A1 (en) Regulation of human phospholipase a2-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU7054101A (en) Regulation of human calcium-independent alpha-latro-toxin-like g protein-coupledreceptor
AU5033101A (en) Regulation of human heparanase-like enzyme
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU1222601A (en) Regulation of gene expression by neuromodulators